Annual EBIT
-$150.89 M
-$51.79 M-52.27%
December 31, 2023
Summary
- As of February 20, 2025, AVDL annual earnings before interest & taxes is -$150.89 million, with the most recent change of -$51.79 million (-52.27%) on December 31, 2023.
- During the last 3 years, AVDL annual EBIT has fallen by -$158.80 million (-2007.12%).
- AVDL annual EBIT is now -261.02% below its all-time high of $93.71 million, reached on December 31, 2017.
Performance
AVDL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
$283.00 K
+$11.90 M+102.44%
September 30, 2024
Summary
- As of February 20, 2025, AVDL quarterly earnings before interest & taxes is $283.00 thousand, with the most recent change of +$11.90 million (+102.44%) on September 30, 2024.
- Over the past year, AVDL quarterly EBIT has increased by +$26.82 million (+101.07%).
- AVDL quarterly EBIT is now -99.28% below its all-time high of $39.40 million, reached on June 30, 2020.
Performance
AVDL Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$62.52 M
+$34.49 M+35.55%
September 30, 2024
Summary
- As of February 20, 2025, AVDL TTM earnings before interest & taxes is -$62.52 million, with the most recent change of +$34.49 million (+35.55%) on September 30, 2024.
- Over the past year, AVDL TTM EBIT has increased by +$88.37 million (+58.57%).
- AVDL TTM EBIT is now -153.22% below its all-time high of $117.48 million, reached on September 30, 2017.
Performance
AVDL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
AVDL EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -52.3% | +101.1% | +58.6% |
| 3 y3 years | -2007.1% | +100.5% | +52.2% |
| 5 y5 years | -47.1% | +100.5% | +52.2% |
AVDL EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -81.3% | at low | at high | +100.5% | at high | +58.6% |
| 5 y | 5-year | -2007.1% | at low | -99.3% | +100.5% | -410.0% | +58.6% |
| alltime | all time | -261.0% | at low | -99.3% | +100.4% | -153.2% | +58.6% |
Avadel Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $283.00 K(-102.4%) | -$62.52 M(-35.6%) |
| Jun 2024 | - | -$11.62 M(-52.9%) | -$97.01 M(-34.2%) |
| Mar 2024 | - | -$24.66 M(-7.1%) | -$147.44 M(-2.3%) |
| Dec 2023 | -$150.89 M(+52.3%) | -$26.53 M(-22.4%) | -$150.89 M(+1.6%) |
| Sep 2023 | - | -$34.21 M(-44.9%) | -$148.47 M(+13.5%) |
| Jun 2023 | - | -$62.05 M(+120.8%) | -$130.77 M(+32.8%) |
| Mar 2023 | - | -$28.11 M(+16.6%) | -$98.47 M(-0.6%) |
| Dec 2022 | -$99.10 M(+19.1%) | -$24.11 M(+46.0%) | -$99.10 M(+1.7%) |
| Sep 2022 | - | -$16.51 M(-44.5%) | -$97.48 M(-8.2%) |
| Jun 2022 | - | -$29.75 M(+3.5%) | -$106.14 M(+8.5%) |
| Mar 2022 | - | -$28.73 M(+27.7%) | -$97.81 M(+17.6%) |
| Dec 2021 | -$83.20 M(-1151.6%) | -$22.49 M(-10.7%) | -$83.20 M(+16.3%) |
| Sep 2021 | - | -$25.17 M(+17.5%) | -$71.53 M(+19.5%) |
| Jun 2021 | - | -$21.42 M(+51.6%) | -$59.84 M(-6244.3%) |
| Mar 2021 | - | -$14.12 M(+30.5%) | $974.00 K(-87.7%) |
| Dec 2020 | $7.91 M(-130.3%) | -$10.82 M(-19.7%) | $7.91 M(-22.3%) |
| Sep 2020 | - | -$13.48 M(-134.2%) | $10.19 M(-49.5%) |
| Jun 2020 | - | $39.40 M(-648.4%) | $20.17 M(-187.9%) |
| Mar 2020 | - | -$7.18 M(-15.9%) | -$22.95 M(-12.1%) |
| Dec 2019 | -$26.10 M(-74.6%) | -$8.55 M(+143.8%) | -$26.10 M(-71.9%) |
| Sep 2019 | - | -$3.50 M(-5.7%) | -$92.90 M(-9.7%) |
| Jun 2019 | - | -$3.72 M(-64.0%) | -$102.86 M(+2.9%) |
| Mar 2019 | - | -$10.33 M(-86.3%) | -$99.94 M(-2.6%) |
| Dec 2018 | -$102.58 M(-209.5%) | -$75.35 M(+459.7%) | -$102.58 M(+214.2%) |
| Sep 2018 | - | -$13.46 M(+1582.8%) | -$32.65 M(-476.4%) |
| Jun 2018 | - | -$800.00 K(-93.8%) | $8.67 M(-81.2%) |
| Mar 2018 | - | -$12.97 M(+139.1%) | $46.03 M(-50.9%) |
| Dec 2017 | $93.71 M(-1170.4%) | -$5.42 M(-119.5%) | $93.71 M(-20.2%) |
| Sep 2017 | - | $27.86 M(-23.8%) | $117.48 M(+60.2%) |
| Jun 2017 | - | $36.56 M(+5.3%) | $73.33 M(+199.0%) |
| Mar 2017 | - | $34.71 M(+89.3%) | $24.53 M(-380.2%) |
| Dec 2016 | -$8.76 M(-111.3%) | $18.34 M(-212.7%) | -$8.76 M(-64.4%) |
| Sep 2016 | - | -$16.28 M(+32.9%) | -$24.59 M(-211.8%) |
| Jun 2016 | - | -$12.25 M(-957.0%) | $21.99 M(-15.0%) |
| Mar 2016 | - | $1.43 M(-43.1%) | $25.89 M(-44.7%) |
| Dec 2015 | $77.70 M(-192.1%) | $2.51 M(-91.7%) | $46.84 M(+283.9%) |
| Sep 2015 | - | $30.30 M(-462.8%) | $12.20 M(-145.7%) |
| Jun 2015 | - | -$8.35 M(-137.3%) | -$26.68 M(-28.5%) |
| Mar 2015 | - | $22.38 M(-169.7%) | -$37.32 M(-55.4%) |
| Dec 2014 | -$84.38 M(+58.7%) | -$32.12 M(+274.0%) | -$83.65 M(+54.8%) |
| Sep 2014 | - | -$8.59 M(-54.8%) | -$54.02 M(+3.2%) |
| Jun 2014 | - | -$18.98 M(-20.8%) | -$52.33 M(-22.2%) |
| Mar 2014 | - | -$23.95 M(+859.7%) | -$67.25 M(+26.5%) |
| Dec 2013 | -$53.16 M(+468.5%) | -$2.50 M(-63.8%) | -$53.16 M(+11.5%) |
| Sep 2013 | - | -$6.90 M(-79.7%) | -$47.68 M(+0.9%) |
| Jun 2013 | - | -$33.91 M(+243.8%) | -$47.26 M(+145.3%) |
| Mar 2013 | - | -$9.86 M(-430.5%) | -$19.27 M(+32.6%) |
| Dec 2012 | -$9.35 M(+9.9%) | $2.98 M(-146.1%) | -$14.53 M(-22.4%) |
| Sep 2012 | - | -$6.47 M(+9.4%) | -$18.72 M(+70.1%) |
| Jun 2012 | - | -$5.92 M(+15.4%) | -$11.01 M(+25.9%) |
| Mar 2012 | - | -$5.13 M(+326.1%) | -$8.74 M(+2.8%) |
| Dec 2011 | -$8.51 M(-2.7%) | -$1.20 M(-197.0%) | -$8.51 M(+104.4%) |
| Sep 2011 | - | $1.24 M(-133.9%) | -$4.16 M(-51.2%) |
| Jun 2011 | - | -$3.65 M(-25.3%) | -$8.53 M(-11.2%) |
| Mar 2011 | - | -$4.89 M(-255.6%) | -$9.60 M(+9.8%) |
| Dec 2010 | -$8.74 M | $3.14 M(-200.5%) | -$8.74 M(-49.8%) |
| Sep 2010 | - | -$3.13 M(-33.9%) | -$17.41 M(-1.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2010 | - | -$4.73 M(+17.3%) | -$17.62 M(+6.7%) |
| Mar 2010 | - | -$4.03 M(-27.0%) | -$16.51 M(+45.6%) |
| Dec 2009 | -$11.34 M(-2.0%) | -$5.52 M(+65.5%) | -$11.34 M(+430.6%) |
| Sep 2009 | - | -$3.34 M(-7.7%) | -$2.14 M(-37.4%) |
| Jun 2009 | - | -$3.62 M(-417.6%) | -$3.42 M(-38.3%) |
| Mar 2009 | - | $1.14 M(-69.0%) | -$5.53 M(-52.2%) |
| Dec 2008 | -$11.57 M(-71.7%) | $3.68 M(-179.7%) | -$11.57 M(-50.4%) |
| Sep 2008 | - | -$4.62 M(-19.5%) | -$23.30 M(-16.6%) |
| Jun 2008 | - | -$5.73 M(+17.1%) | -$27.95 M(-22.8%) |
| Mar 2008 | - | -$4.89 M(-39.3%) | -$36.23 M(-11.3%) |
| Dec 2007 | -$40.85 M(+5.2%) | -$8.06 M(-13.0%) | -$40.85 M(-1.0%) |
| Sep 2007 | - | -$9.26 M(-33.9%) | -$41.26 M(-3.2%) |
| Jun 2007 | - | -$14.01 M(+47.1%) | -$42.64 M(+11.6%) |
| Mar 2007 | - | -$9.52 M(+12.4%) | -$38.21 M(-1.6%) |
| Dec 2006 | -$38.84 M(-4.7%) | -$8.47 M(-20.5%) | -$38.84 M(-6.3%) |
| Sep 2006 | - | -$10.64 M(+11.0%) | -$41.46 M(-3.6%) |
| Jun 2006 | - | -$9.59 M(-5.5%) | -$43.00 M(-0.8%) |
| Mar 2006 | - | -$10.14 M(-8.5%) | -$43.33 M(+6.3%) |
| Dec 2005 | -$40.77 M(-561.4%) | -$11.09 M(-8.9%) | -$40.77 M(+65.3%) |
| Sep 2005 | - | -$12.18 M(+22.8%) | -$24.66 M(+138.0%) |
| Jun 2005 | - | -$9.92 M(+30.8%) | -$10.36 M(+309.6%) |
| Mar 2005 | - | -$7.58 M(-251.0%) | -$2.53 M(-128.6%) |
| Dec 2004 | $8.84 M(-288.0%) | $5.02 M(+137.1%) | $8.84 M(+169.7%) |
| Sep 2004 | - | $2.12 M(-201.5%) | $3.28 M(-662.9%) |
| Jun 2004 | - | -$2.08 M(-155.1%) | -$582.00 K(+144.5%) |
| Mar 2004 | - | $3.78 M(-800.7%) | -$238.00 K(-96.3%) |
| Dec 2003 | -$4.70 M(+2007.2%) | -$540.00 K(-69.0%) | -$6.44 M(-31.3%) |
| Sep 2003 | - | -$1.74 M(0.0%) | -$9.37 M(+73.3%) |
| Jun 2003 | - | -$1.74 M(-28.0%) | -$5.41 M(-506.4%) |
| Mar 2003 | - | -$2.42 M(-30.4%) | $1.33 M(-84.0%) |
| Dec 2002 | -$223.00 K(-92.9%) | -$3.47 M(-256.3%) | $8.31 M(+8046.1%) |
| Sep 2002 | - | $2.22 M(-55.5%) | $102.00 K(-79.8%) |
| Jun 2002 | - | $5.00 M(+9.6%) | $504.00 K(-124.4%) |
| Mar 2002 | - | $4.56 M(-139.0%) | -$2.06 M(-34.6%) |
| Dec 2001 | -$3.15 M(-80.4%) | -$11.68 M(-545.0%) | -$3.15 M(-79.8%) |
| Sep 2001 | - | $2.63 M(+7.9%) | -$15.58 M(+2.5%) |
| Jun 2001 | - | $2.43 M(-29.8%) | -$15.21 M(+2.8%) |
| Mar 2001 | - | $3.47 M(-114.4%) | -$14.80 M(-9.1%) |
| Dec 2000 | -$16.11 M(+130.1%) | -$24.11 M(-903.6%) | -$16.28 M(+407.6%) |
| Sep 2000 | - | $3.00 M(+5.6%) | -$3.21 M(-29.0%) |
| Jun 2000 | - | $2.84 M(+43.4%) | -$4.52 M(-28.4%) |
| Mar 2000 | - | $1.98 M(-118.0%) | -$6.32 M(-9.7%) |
| Dec 1999 | -$7.00 M(-24.7%) | -$11.03 M(-753.6%) | -$7.00 M(-41.0%) |
| Sep 1999 | - | $1.69 M(+61.4%) | -$11.86 M(+0.1%) |
| Jun 1999 | - | $1.05 M(-19.5%) | -$11.85 M(+16.2%) |
| Mar 1999 | - | $1.30 M(-108.2%) | -$10.19 M(-28.7%) |
| Dec 1998 | -$9.29 M(+3.2%) | -$15.89 M(-1034.8%) | -$14.29 M(+18.1%) |
| Sep 1998 | - | $1.70 M(-37.0%) | -$12.10 M(-4.0%) |
| Jun 1998 | - | $2.70 M(-196.4%) | -$12.60 M(-10.0%) |
| Mar 1998 | - | -$2.80 M(-79.6%) | -$14.00 M(+53.8%) |
| Dec 1997 | -$9.00 M(0.0%) | -$13.70 M(-1241.7%) | -$9.10 M(+12.3%) |
| Sep 1997 | - | $1.20 M(-7.7%) | -$8.10 M(-5.8%) |
| Jun 1997 | - | $1.30 M(-38.1%) | -$8.60 M(-4.4%) |
| Mar 1997 | - | $2.10 M(-116.5%) | -$9.00 M(-26.2%) |
| Dec 1996 | -$9.00 M | -$12.70 M(-1914.3%) | -$12.20 M(-2540.0%) |
| Sep 1996 | - | $700.00 K(-22.2%) | $500.00 K(-350.0%) |
| Jun 1996 | - | $900.00 K(-181.8%) | -$200.00 K(-81.8%) |
| Mar 1996 | - | -$1.10 M | -$1.10 M |
FAQ
- What is Avadel Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals annual EBIT year-on-year change?
- What is Avadel Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals quarterly EBIT year-on-year change?
- What is Avadel Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals TTM EBIT year-on-year change?
What is Avadel Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of AVDL is -$150.89 M
What is the all time high annual EBIT for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high annual earnings before interest & taxes is $93.71 M
What is Avadel Pharmaceuticals annual EBIT year-on-year change?
Over the past year, AVDL annual earnings before interest & taxes has changed by -$51.79 M (-52.27%)
What is Avadel Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of AVDL is $283.00 K
What is the all time high quarterly EBIT for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high quarterly earnings before interest & taxes is $39.40 M
What is Avadel Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, AVDL quarterly earnings before interest & taxes has changed by +$26.82 M (+101.07%)
What is Avadel Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of AVDL is -$62.52 M
What is the all time high TTM EBIT for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high TTM earnings before interest & taxes is $117.48 M
What is Avadel Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, AVDL TTM earnings before interest & taxes has changed by +$88.37 M (+58.57%)